Liraglutide and tirzepatide are effective for weight loss but have a poorer safety profile and higher discontinuation rates due to adverse events
Accelerated healing Protects tissue from ongoing damage Shields tissue from oxidative stress TB-500 The Logistics Coordinator TB-500 is known as the coordinator because of its role in communication within the body
In head-to-head trials, tirzepatide's dual-receptor mechanism (GLP-1 plus GIP) tended to produce larger average weight loss than semaglutide, which targets GLP-1 alone
Physiology (Bethesda), 38(5):0 Prausmller S, Weidenhammer A, Heitzinger G, Spinka G, Goliasch G, Arfsten H, Abdel Mawgoud R, Gabler C, Strunk G, Hengstenberg C et al (2023) Obesity in heart failure with preserved ejection fraction with and without diabetes: risk factor or innocent bystander
Human clinical trials for the specific GLP3 + cagrilintide combination are absent from peer-reviewed literature